<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39468306</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>29</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>28</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>The circulating characteristics of common respiratory pathogens in Ningbo, China, both before and following the cessation of COVID-19 containment measures.</ArticleTitle><Pagination><StartPage>25876</StartPage><MedlinePgn>25876</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-024-77456-w</ELocationID><Abstract><AbstractText>To assess the circulating characteristics of common respiratory pathogens following the complete relaxation of non-pharmaceutical interventions (NPIs) and the cessation of the dynamic zero-COVID policy. The retrospective analysis was conducted from 14,412 patients with acute respiratory infections (ARIs) from January 24, 2020, to December 31, 2023, including Influenza A virus (IFV-A), Influenza B virus (IFV-B), Respiratory Syncytial Virus (RSV), Human Rhinovirus (HRV), Human Parainfluenza Virus (HPIV), Human Metapneumovirus (HMPV), Human Coronavirus (HCoV), Human Bocavirus (HBoV), Human Adenovirus (HAdV), and Mycoplasma pneumoniae (MP). Compared with 2020-2022, Joinpoint analysis indicated a monthly increase in overall pathogen activity in 2023, rising from an average of 43.05% to an average of 68.46%. The positive rates of IFV-A, IFV-B, HMPV, HPIV, HCoV, and MP increased, while those of HRV and RSV decreased, and no differences in HAdV and HBoV. The outbreak of IFV-A and MP was observed, the positive rate of MP has surpassed pre-COVID-19 pandemic levels and the spread of RSV was interrupted by IFV-A. Infants and toddlers were primarily infected by HRV and RSV, Children and adolescents exhibited a higher prevalence of infections with MP, IFV-A, and HRV, whereas Adults and the elderly were primarily infected by IFV-A. The incidence of co-infections rose from 4.25 to 13.73%. Restricted cubic spline models showed that the susceptible age ranges for multiple pathogens expanded. These changes serve as a reminder to stay alert in the future and offer clinicians a useful guide for diagnosing and treating.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Qian</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, The Affiliated LiHuiLi Hospital of Ningbo University, Ningbo University, Ningbo, 315040, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Zhen</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, The Affiliated LiHuiLi Hospital of Ningbo University, Ningbo University, Ningbo, 315040, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Min</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, The Affiliated LiHuiLi Hospital of Ningbo University, Ningbo University, Ningbo, 315040, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Qinhong</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, The Affiliated LiHuiLi Hospital of Ningbo University, Ningbo University, Ningbo, 315040, China. 19564814933@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tu</LastName><ForeName>Yanye</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, The Affiliated LiHuiLi Hospital of Ningbo University, Ningbo University, Ningbo, 315040, China. tuyanye9199@126.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>Grant No.2021KY304</GrantID><Agency>Medical and Health Research Project of Zhejiang Province</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012141" MajorTopicYN="Y">Respiratory Tract Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029121" MajorTopicYN="N">Metapneumovirus</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>29</Day><Hour>6</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>29</Day><Hour>6</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>29</Day><Hour>1</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39468306</ArticleId><ArticleId IdType="doi">10.1038/s41598-024-77456-w</ArticleId><ArticleId IdType="pii">10.1038/s41598-024-77456-w</ArticleId></ArticleIdList><ReferenceList><Title /><Reference><Citation>Global burden of 369 diseases. and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019.</Citation></Reference><Reference><Citation>Narasimhan, H., Wu, Y., Goplen, N. P. &amp; Sun, J. Immune determinants of chronic sequelae after respiratory viral infection. Sci. Immunol. 7, eabm7996. https://doi.org/10.1126/sciimmunol.abm7996 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abm7996</ArticleId><ArticleId IdType="pubmed">35857581</ArticleId></ArticleIdList></Reference><Reference><Citation>Leung, N. H. L. Transmissibility and transmission of respiratory viruses. Nat. Rev. Microbiol. 19, 528–545. https://doi.org/10.1038/s41579-021-00535-6 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-021-00535-6</ArticleId><ArticleId IdType="pubmed">33753932</ArticleId><ArticleId IdType="pmc">7982882</ArticleId></ArticleIdList></Reference><Reference><Citation>Padayachee, Y., Faiez, T. S., Singanayagam, A., Mallia, P. &amp; Johnston, S. L. Asthma and viruses: a focus on rhinoviruses and SARS-CoV-2. J. Allergy Clin. Immunol. 147, 1648–1651. https://doi.org/10.1016/j.jaci.2021.03.011 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2021.03.011</ArticleId><ArticleId IdType="pubmed">33727064</ArticleId><ArticleId IdType="pmc">7955806</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren, Y. et al. Development and validation of a nomogram for predicting Mycoplasma pneumoniae pneumonia in adults. Sci. Rep. 12, 21859. https://doi.org/10.1038/s41598-022-26565-5 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-26565-5</ArticleId><ArticleId IdType="pubmed">36528731</ArticleId><ArticleId IdType="pmc">9759542</ArticleId></ArticleIdList></Reference><Reference><Citation>McElhaney, J. E. et al. The immune response to influenza in older humans: beyond immune senescence. Immun. Ageing: I a. 17. https://doi.org/10.1186/s12979-020-00181-1 (2020).</Citation></Reference><Reference><Citation>Mazur, N. I. et al. The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates. Lancet Infect. Dis. 18, e295–e311. https://doi.org/10.1016/s1473-3099(18)30292-5 (2018).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1473-3099(18)30292-5</ArticleId><ArticleId IdType="pubmed">29914800</ArticleId></ArticleIdList></Reference><Reference><Citation>Koh, H. K., Geller, A. C. &amp; VanderWeele, T. J. Deaths from COVID-19. Jama. 325, 133–134. https://doi.org/10.1001/jama.2020.25381 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.25381</ArticleId><ArticleId IdType="pubmed">33331884</ArticleId></ArticleIdList></Reference><Reference><Citation>Amar, S., Avni, Y. S., O’Rourke, N. &amp; Michael, T. Prevalence of common infectious diseases after COVID-19 Vaccination and Easing of Pandemic restrictions in Israel. JAMA Netw. Open. 5, e2146175. https://doi.org/10.1001/jamanetworkopen.2021.46175 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.46175</ArticleId><ArticleId IdType="pubmed">35103792</ArticleId><ArticleId IdType="pmc">8808334</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer, R. et al. The increase in invasive bacterial infections with respiratory transmission in Germany, 2022/2023. Deutsches Arzteblatt Int. 121, 114–120. https://doi.org/10.3238/arztebl.m2023.0261 (2024).</Citation><ArticleIdList><ArticleId IdType="doi">10.3238/arztebl.m2023.0261</ArticleId></ArticleIdList></Reference><Reference><Citation>The Lancet Regional Health- &amp; Western, P. The end of zero-COVID-19 policy is not the end of COVID-19 for China. Lancet Reg. Health West. Pac. 30, 100702. https://doi.org/10.1016/j.lanwpc.2023.100702 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanwpc.2023.100702</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong, C. et al. Increase of respiratory illnesses among children in Beijing, China, during the autumn and winter of 2023. Euro. Surveillance: Bull. Europeen sur les maladies Transmissibles = Eur. Commun. Disease Bull. 29. https://doi.org/10.2807/1560-7917.Es.2024.29.2.2300704 (2024).</Citation></Reference><Reference><Citation>Wang, X. et al. Unraveling the global burden of inflammatory bowel disease (1990–2019): a Joinpoint regression analysis of divergent trends in 10–24 and 50–69 age cohorts. Autoimmun. rev. 103586. https://doi.org/10.1016/j.autrev.2024.103586 (2024).</Citation></Reference><Reference><Citation>Liu, P. &amp; Xu, J. Resurgence of influenza virus activity during COVID-19 pandemic in Shanghai, China. J. Infect. https://doi.org/10.1016/j.jinf.2022.09.025 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2022.09.025</ArticleId><ArticleId IdType="pubmed">36516903</ArticleId><ArticleId IdType="pmc">9741555</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, Y. et al. Cocirculation and coinfection of multiple respiratory viruses during autumn and winter seasons of 2023 in Beijing, China: a retrospective study. J. Med. Virol. 96, e29602. https://doi.org/10.1002/jmv.29602 (2024).</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.29602</ArticleId><ArticleId IdType="pubmed">38597349</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu, A. Q., Li, Z. J. &amp; Zhang, H. J. Spatial timing of circulating seasonal influenza A and B viruses in China from 2014 to 2018. Sci. Rep. 13, 7149. https://doi.org/10.1038/s41598-023-33726-7 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-33726-7</ArticleId><ArticleId IdType="pubmed">37130872</ArticleId><ArticleId IdType="pmc">10154288</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer Sauteur, P. M. &amp; Beeton, M. L. Mycoplasma pneumoniae: gone forever? Lancet Microbe. 4, e763. https://doi.org/10.1016/s2666-5247(23)00182-9 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2666-5247(23)00182-9</ArticleId><ArticleId IdType="pubmed">37393927</ArticleId></ArticleIdList></Reference><Reference><Citation>Urbieta, A. D. et al. Mycoplasma pneumoniae at the rise not only in China: Rapid increase of Mycoplasma pneumoniae cases also in Spain. Emerg. Microbes Infect. 2332680. https://doi.org/10.1080/22221751.2024.2332680 (2024).</Citation></Reference><Reference><Citation>Wreghitt, T. Mycoplasma pneumoniae: current outbreak. Epidemiol. Infect. 1–3. https://doi.org/10.1017/s0950268824000293 (2024).</Citation></Reference><Reference><Citation>Yan, C. et al. Current status of Mycoplasma pneumoniae infection in China. World J. Pediatrics: WJP. https://doi.org/10.1007/s12519-023-00783-x (2024).</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12519-023-00783-x</ArticleId><ArticleId IdType="pubmed">38216847</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang, Q., Yang, F., Peng, Y., Dong, X. &amp; Ge, Y. Epidemiology and molecular identification of mycoplasma pneumoniae associated with respiratory infections in Zhejiang Province, China, 2008–2017. J. Clin. Lab. Anal. 34, e23460. https://doi.org/10.1002/jcla.23460 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcla.23460</ArticleId><ArticleId IdType="pubmed">32666532</ArticleId><ArticleId IdType="pmc">7676177</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim, H. M. et al. Impact of coronavirus disease 2019 on respiratory surveillance and explanation of high detection rate of human rhinovirus during the pandemic in the Republic of Korea. Influenza Other Respir. Viruses. 15, 721–731. https://doi.org/10.1111/irv.12894 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/irv.12894</ArticleId><ArticleId IdType="pubmed">34405546</ArticleId><ArticleId IdType="pmc">8446939</ArticleId></ArticleIdList></Reference><Reference><Citation>Saravanos, G. L. et al. RSV epidemiology in Australia before and during COVID-19. Pediatrics. 149. https://doi.org/10.1542/peds.2021-053537 (2022).</Citation></Reference><Reference><Citation>Jia, R. et al. Resurgence of respiratory syncytial virus infection during COVID-19 pandemic among children in Shanghai, China. Front. Microbiol. 13, 938372. https://doi.org/10.3389/fmicb.2022.938372 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2022.938372</ArticleId><ArticleId IdType="pubmed">35875547</ArticleId><ArticleId IdType="pmc">9298468</ArticleId></ArticleIdList></Reference><Reference><Citation>Ujiie, M., Tsuzuki, S., Nakamoto, T. &amp; Iwamoto, N. Resurgence of respiratory Syncytial Virus infections during COVID-19 pandemic, Tokyo, Japan. Emerg. Infect. Dis. 27, 2969–2970. https://doi.org/10.3201/eid2711.211565 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2711.211565</ArticleId><ArticleId IdType="pubmed">34388086</ArticleId><ArticleId IdType="pmc">8544984</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, G. et al. Epidemiological changes in respiratory pathogen transmission among children with acute respiratory infections during the COVID-19 pandemic in Kunming, China. BMC Infect. Dis. 24, 826. https://doi.org/10.1186/s12879-024-09733-y (2024).</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-024-09733-y</ArticleId><ArticleId IdType="pubmed">39143516</ArticleId><ArticleId IdType="pmc">11323578</ArticleId></ArticleIdList></Reference><Reference><Citation>van Asten, L. et al. Early occurrence of influenza A epidemics coincided with changes in occurrence of other respiratory virus infections. Influenza Other Respir. Viruses. 10, 14–26. https://doi.org/10.1111/irv.12348 (2016).</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/irv.12348</ArticleId><ArticleId IdType="pubmed">26369646</ArticleId></ArticleIdList></Reference><Reference><Citation>Kieninger, E., Fuchs, O., Latzin, P., Frey, U. &amp; Regamey, N. Rhinovirus infections in infancy and early childhood. Eur. Respir. J. 41, 443–452. https://doi.org/10.1183/09031936.00203511 (2013).</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00203511</ArticleId><ArticleId IdType="pubmed">22743674</ArticleId></ArticleIdList></Reference><Reference><Citation>Billard, M. N. &amp; Bont, L. RSV immunisation: lessons from the COVID-19 pandemic. Lancet Child. Adolesc. Health. 7, 147–149. https://doi.org/10.1016/S2352-4642(22)00377-7 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(22)00377-7</ArticleId><ArticleId IdType="pubmed">36634693</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, L., Jia, R., Zhang, Y., Sun, H. &amp; Ma, J. Changes of parainfluenza virus infection in children before and after the COVID-19 pandemic in Henan, China. J. Infect. https://doi.org/10.1016/j.jinf.2023.02.009 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2023.02.009</ArticleId><ArticleId IdType="pubmed">38251473</ArticleId><ArticleId IdType="pmc">10114314</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee, K. L. et al. Severe Mycoplasma pneumoniae pneumonia requiring intensive care in children, 2010–2019. J. Formos. Med. Association = Taiwan. Yi Zhi. 120, 281–291. https://doi.org/10.1016/j.jfma.2020.08.018 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jfma.2020.08.018</ArticleId><ArticleId IdType="pubmed">32948415</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee, E. et al. Annual and seasonal patterns in etiologies of pediatric community-acquired pneumonia due to respiratory viruses and Mycoplasma pneumoniae requiring hospitalization in South Korea. BMC Infect. Dis. 20, 132. https://doi.org/10.1186/s12879-020-4810-9 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-020-4810-9</ArticleId><ArticleId IdType="pubmed">32050912</ArticleId><ArticleId IdType="pmc">7017508</ArticleId></ArticleIdList></Reference><Reference><Citation>Iyengar, P. et al. Case-ascertained study of household transmission of seasonal influenza - South Africa, 2013. J. Infect. 71, 578–586. https://doi.org/10.1016/j.jinf.2015.09.001 (2015).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2015.09.001</ArticleId><ArticleId IdType="pubmed">26366941</ArticleId><ArticleId IdType="pmc">4667753</ArticleId></ArticleIdList></Reference><Reference><Citation>Emanuels, A. et al. Remote Household Observation for Noninfluenza respiratory viral illness. Clin. Infect. Diseases: Official Publication Infect. Dis. Soc. Am. 73, e4411–e4418. https://doi.org/10.1093/cid/ciaa1719 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1719</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas, C. M. et al. Early and increased influenza activity among Children - Tennessee, 2022-23 influenza season. MMWR Morb. Mortal. Wkly Rep. 72, 49–54. https://doi.org/10.15585/mmwr.mm7203a1 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7203a1</ArticleId><ArticleId IdType="pubmed">36656786</ArticleId><ArticleId IdType="pmc">9869745</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, J., Yang, T., Zou, M., Wang, L. &amp; Sai, L. The epidemiological features of respiratory tract infection using the multiplex panels detection during COVID-19 pandemic in Shandong province, China. Sci. Rep. 13, 6319. https://doi.org/10.1038/s41598-023-33627-9 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-33627-9</ArticleId><ArticleId IdType="pubmed">37072619</ArticleId><ArticleId IdType="pmc">10112310</ArticleId></ArticleIdList></Reference><Reference><Citation>Nickbakhsh, S. et al. Virus-virus interactions impact the population dynamics of influenza and the common cold. Proc. Natl. Acad. Sci. U.S.A. 116, 27142–27150. https://doi.org/10.1073/pnas.1911083116 (2019).</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1911083116</ArticleId><ArticleId IdType="pubmed">31843887</ArticleId><ArticleId IdType="pmc">6936719</ArticleId></ArticleIdList></Reference><Reference><Citation>Weidmann, M. D., Green, D. A., Berry, G. J. &amp; Wu, F. Assessing respiratory viral exclusion and affinity interactions through co-infection incidence in a pediatric population during the 2022 resurgence of influenza and RSV. Front. Cell. Infect. Microbiol. 13, 1208235. https://doi.org/10.3389/fcimb.2023.1208235 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2023.1208235</ArticleId><ArticleId IdType="pubmed">37389220</ArticleId><ArticleId IdType="pmc">10302716</ArticleId></ArticleIdList></Reference><Reference><Citation>Gauthier, J., Wu, Q. V. &amp; Gooley, T. A. Cubic splines to model relationships between continuous variables and outcomes: a guide for clinicians. Bone Marrow Transplant. 55, 675–680. https://doi.org/10.1038/s41409-019-0679-x (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41409-019-0679-x</ArticleId><ArticleId IdType="pubmed">31576022</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang, M. et al. Influence of non-pharmaceutical interventions on epidemiological characteristics of Mycoplasma pneumoniae infection in children during and after the COVID-19 epidemic in Ningbo, China. Front. Microbiol. 15, 1405710. https://doi.org/10.3389/fmicb.2024.1405710 (2024).</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2024.1405710</ArticleId><ArticleId IdType="pubmed">39086655</ArticleId><ArticleId IdType="pmc">11288959</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh, C. et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat. Immunol. 23, 210–216. https://doi.org/10.1038/s41590-021-01113-x (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu, W. &amp; Gu, L. Resurgence of seasonal influenza driven by A/H3N2 and B/Victoria in succession during the 2023–2024 season in Beijing showing increased population susceptibility. J. Med. Virol. 96, e29751. https://doi.org/10.1002/jmv.29751 (2024).</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.29751</ArticleId><ArticleId IdType="pubmed">38884384</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, K. et al. Temporal shifts in 24 notifiable infectious diseases in China before and during the COVID-19 pandemic. Nat. Commun. 15, 3891. https://doi.org/10.1038/s41467-024-48201-8 (2024).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-024-48201-8</ArticleId><ArticleId IdType="pubmed">38719858</ArticleId><ArticleId IdType="pmc">11079007</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, Q. et al. Increased population susceptibility to seasonal influenza during the COVID-19 pandemic in China and the United States. J. Med. Virol. 95, e29186. https://doi.org/10.1002/jmv.29186 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.29186</ArticleId><ArticleId IdType="pubmed">37855656</ArticleId></ArticleIdList></Reference><Reference><Citation>Chow, E. J., Uyeki, T. M. &amp; Chu, H. Y. The effects of the COVID-19 pandemic on community respiratory virus activity. Nat. Rev. Microbiol. 21, 195–210. https://doi.org/10.1038/s41579-022-00807-9 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00807-9</ArticleId><ArticleId IdType="pubmed">36253478</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>